Icilma V Fergus MD
Interventional Cardiology
Associate Professor, Medicine, Mount Sinai School of Medicine
Join to View Full Profile
1 Gustave L Levy PlSte 29903New York, NY 10029
Phone+1 212-241-3271
Fax+1 212-348-7908
Dr. Fergus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1996 - 1999
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1992 - 1995
State University of New York Downstate Medical Center College of MedicineClass of 1992
Certifications & Licensure
NY State Medical License 1997 - 2026
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 8 citationsRationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, M Urooj Zafar
Cardiovascular Drugs and Therapy. 2025-02-01 - 5 citationsBioprosthetic Valve Thrombosis Associated with COVID-19 Infection.Steven A. Alexander, Icilma V. Fergus, Stamatios Lerakis
Circulation. Cardiovascular Imaging. 2021-02-05 - 300 citationsRandomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.Carlos G. Santos-Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibanez, Alvaro Garcia-Ropero, Donna M. Mancini
Journal of the American College of Cardiology. 2021-01-26
Press Mentions
Here and Now 4/6/25: Impacts of Weight Loss Drugs on Heart Health in Communities of ColorApril 6th, 2025- Some Winter Viruses Could Trigger Heart Complications, Experts WarnFebruary 1st, 2025
- KMN 2025: How Symptoms of Viral Influenza, COVID-19, Norovirus, and RSV Will Be Indicators of Potential Coronary Heart IssuesJanuary 25th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
